Skip to content

Cooper Companies

NASDAQ: COO · USD

Cooper Companies revenue98

Quarterly and annual revenue from company filings.

Business drivers

Business lines and operating measures.

Total CooperVision net sales · Operating Segments

Reported quarterly Total CooperVision net sales · Operating Segments. Quarterly figures · USD

Total CooperVision net sales · Operating Segments. Reported quarterly Total CooperVision net sales · Operating Segments. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jul 31, 2026From May 1, 2026717,000,000Filed Sep 9, 2026
Apr 30, 2026From Feb 1, 2026723,500,000Filed Jun 5, 2026
Jul 31, 2025From May 1, 2025718,400,000Filed Sep 9, 2026
Apr 30, 2025From Feb 1, 2025669,600,000Filed Jun 5, 2026

Office And Surgical · Coopersurgical Segment · Operating Segments revenue

Reported quarterly Office And Surgical · Coopersurgical Segment · Operating Segments revenue. Quarterly figures · USD

Office And Surgical · Coopersurgical Segment · Operating Segments revenue. Reported quarterly Office And Surgical · Coopersurgical Segment · Operating Segments revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jul 31, 2026From May 1, 2026208,000,000Filed Sep 9, 2026
Apr 30, 2026From Feb 1, 2026214,200,000Filed Jun 5, 2026
Jul 31, 2025From May 1, 2025204,800,000Filed Sep 9, 2026
Apr 30, 2025From Feb 1, 2025205,800,000Filed Jun 5, 2026

Fertility · Coopersurgical Segment · Operating Segments revenue

Reported quarterly Fertility · Coopersurgical Segment · Operating Segments revenue. Quarterly figures · USD

Fertility · Coopersurgical Segment · Operating Segments revenue. Reported quarterly Fertility · Coopersurgical Segment · Operating Segments revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jul 31, 2026From May 1, 2026141,200,000Filed Sep 9, 2026
Apr 30, 2026From Feb 1, 2026143,800,000Filed Jun 5, 2026
Jul 31, 2025From May 1, 2025137,100,000Filed Sep 9, 2026
Apr 30, 2025From Feb 1, 2025126,900,000Filed Jun 5, 2026

Independent series; they may overlap and do not form an additive breakdown.

  • Quarterly observations cover only part of each fiscal year; disclosed seasonality limits sequential comparisons.

Products & projects

clariti, MyDay and MyDay Energys

Our single-use silicone hydrogel product franchises, clariti, MyDay and MyDay Energys remain a focus as we expect increasing demand for these products, as well as future single-use products, as the global contact lens market continues to shift to this modality.

Filed · source for clariti, MyDay and MyDay Energys

Revenue history

USD millions · Fiscal periods
Jul 31, 2010 through Jul 31, 2026

Quarterly data

Cooper Companies quarterly financial data in USD millions. FY denotes the company's fiscal year. YTD covers reported quarters only.
Fiscal quarterEndedTotal revenueUSD millions
FY 2026 Q3Jul 31, 20261,066.2, −1.4% versus FY 2026 Q2
FY 2026 Q2Apr 30, 20261,081.5, +5.6% versus FY 2026 Q1
FY 2026 Q1Jan 31, 20261,024.1, −3.8% versus FY 2025 Q4
FY 2025 Q4Oct 31, 20251,065.1, +0.5% versus FY 2025 Q3
FY 2025 Q3Jul 31, 20251,060.3, +5.8% versus FY 2025 Q2
FY 2025 Q2Apr 30, 20251,002.3, +3.9% versus FY 2025 Q1
FY 2025 Q1Jan 31, 2025964.7, −5.3% versus FY 2024 Q4
FY 2024 Q4Oct 31, 20241,018.4, +1.6% versus FY 2024 Q3
FY 2024 Q3Jul 31, 20241,002.8, +6.4% versus FY 2024 Q2
FY 2024 Q2Apr 30, 2024942.6, +1.2% versus FY 2024 Q1
FY 2024 Q1Jan 31, 2024931.6, +0.5% versus FY 2023 Q4
FY 2023 Q4Oct 31, 2023927.1, −0.3% versus FY 2023 Q3
FY 2023 Q3Jul 31, 2023930.2, +6.0% versus FY 2023 Q2
FY 2023 Q2Apr 30, 2023877.4, +2.2% versus FY 2023 Q1
FY 2023 Q1Jan 31, 2023858.5, +1.2% versus FY 2022 Q4
FY 2022 Q4Oct 31, 2022848.1, +0.6% versus FY 2022 Q3
FY 2022 Q3Jul 31, 2022843.4, +1.6% versus FY 2022 Q2
FY 2022 Q2Apr 30, 2022829.8, +5.4% versus FY 2022 Q1
FY 2022 Q1Jan 31, 2022787.2, +3.7% versus FY 2021 Q4
FY 2021 Q4Oct 31, 2021759.1, −0.6% versus FY 2021 Q3
FY 2021 Q3Jul 31, 2021763.4, +6.1% versus FY 2021 Q2
FY 2021 Q2Apr 30, 2021719.5, +5.7% versus FY 2021 Q1
FY 2021 Q1Jan 31, 2021680.5, −0.2% versus FY 2020 Q4
FY 2020 Q4Oct 31, 2020681.6, +17.9% versus FY 2020 Q3
FY 2020 Q3Jul 31, 2020578.2, +10.2% versus FY 2020 Q2
FY 2020 Q2Apr 30, 2020524.9, −18.8% versus FY 2020 Q1
FY 2020 Q1Jan 31, 2020646.2, −6.6% versus FY 2019 Q4
FY 2019 Q4Oct 31, 2019691.6, +1.8% versus FY 2019 Q3
FY 2019 Q3Jul 31, 2019679.4, +3.8% versus FY 2019 Q2
FY 2019 Q2Apr 30, 2019654.3, +4.2% versus FY 2019 Q1
FY 2019 Q1Jan 31, 2019628.1, −3.6% versus FY 2018 Q4
FY 2018 Q4Oct 31, 2018651.5, −1.3% versus FY 2018 Q3
FY 2018 Q3Jul 31, 2018660, +4.5% versus FY 2018 Q2
FY 2018 Q2Apr 30, 2018631.3, +7.0% versus FY 2018 Q1
FY 2018 Q1Jan 31, 2018590, +5.1% versus FY 2017 Q4
FY 2017 Q4Oct 31, 2017561.5, +1.0% versus FY 2017 Q3
FY 2017 Q3Jul 31, 2017556, +6.4% versus FY 2017 Q2
FY 2017 Q2Apr 30, 2017522.4, +4.7% versus FY 2017 Q1
FY 2017 Q1Jan 31, 2017499.1, −3.8% versus FY 2016 Q4
FY 2016 Q4Oct 31, 2016518.7, +0.8% versus FY 2016 Q3
FY 2016 Q3Jul 31, 2016514.726, +6.4% versus FY 2016 Q2
FY 2016 Q2Apr 30, 2016483.793, +7.6% versus FY 2016 Q1
FY 2016 Q1Jan 31, 2016449.641, −1.3% versus FY 2015 Q4
FY 2015 Q4Oct 31, 2015455.5, −1.3% versus FY 2015 Q3
FY 2015 Q3Jul 31, 2015461.678, +6.2% versus FY 2015 Q2
FY 2015 Q2Apr 30, 2015434.676, −2.4% versus FY 2015 Q1
FY 2015 Q1Jan 31, 2015445.171, −4.9% versus FY 2014 Q4
FY 2014 Q4Oct 31, 2014467.997, +8.2% versus FY 2014 Q3
FY 2014 Q3Jul 31, 2014432.482, +4.9% versus FY 2014 Q2
FY 2014 Q2Apr 30, 2014412.317, +1.8% versus FY 2014 Q1
FY 2014 Q1Jan 31, 2014404.98, −1.7% versus FY 2013 Q4
FY 2013 Q4Oct 31, 2013411.852, 0.0% versus FY 2013 Q3
FY 2013 Q3Jul 31, 2013411.993, +7.3% versus FY 2013 Q2
FY 2013 Q2Apr 30, 2013384.041, +1.1% versus FY 2013 Q1
FY 2013 Q1Jan 31, 2013379.839, −4.2% versus FY 2012 Q4
FY 2012 Q4Oct 31, 2012396.301, +4.8% versus FY 2012 Q3
FY 2012 Q3Jul 31, 2012378.186, +9.7% versus FY 2012 Q2
FY 2012 Q2Apr 30, 2012344.589, +5.7% versus FY 2012 Q1
FY 2012 Q1Jan 31, 2012326.06, −9.7% versus FY 2011 Q4
FY 2011 Q4Oct 31, 2011360.909, +2.7% versus FY 2011 Q3
FY 2011 Q3Jul 31, 2011351.396, +8.0% versus FY 2011 Q2
FY 2011 Q2Apr 30, 2011325.301, +10.9% versus FY 2011 Q1
FY 2011 Q1Jan 31, 2011293.229, −6.4% versus FY 2010 Q4
FY 2010 Q4Oct 31, 2010313.353, +6.0% versus FY 2010 Q3
FY 2010 Q3Jul 31, 2010295.635, Change unavailable versus FY 2010 Q2
Sources and definitions

Figures from official company filings and financial reports, in the reported currency. FY identifies the fiscal year; the end date identifies the calendar period. Last checked Oct 19, 2026.

Annual values come from annual filings. Historical quarters retain their reporting basis; rounding and reclassifications can make their sum differ from the annual figure. YTD sums the available fiscal quarters and compares the same quarters of the previous fiscal year.

Missing values are shown as unavailable. Fourth quarters use reported values where available, otherwise the annual amount less the matching nine-month amount.

Total revenue
Reported consolidated revenue from the issuer filing. Each observation identifies its accounting concept; bank net revenue is net of interest expense when that concept is reported.
Annual and quarterly differences
  • FY 2015 · Total revenue: annual 1,797.06, quarter sum 1,797.025 USD millions.
  • FY 2016 · Total revenue: annual 1,966.814, quarter sum 1,966.86 USD millions.
  • FY 2022 · Total revenue: annual 3,308.4, quarter sum 3,308.5 USD millions.